Clinical Trials Directory

Trials / Completed

CompletedNCT06336772

Restylane Shaype Versus Juvederm Volux for Chin Augmentation

A Comparative Trial Evaluating Restylane Shaype Versus Juvederm Volux for Chin Augmentation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Erevna Innovations Inc. · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study aims to compare two injectable products (Restylane Shaype and Juvéderm Volux) for aesthetic augmentation of the chin

Conditions

Interventions

TypeNameDescription
DEVICERestylane ShaypeHalf (50%) of study participants will receive Restylane Shaype for the treatment of mild to severe chin retrusion
DEVICEJuvéderm VoluxHalf (50%) of study participants will receive Juvéderm Volux for the treatment of mild to severe chin retrusion

Timeline

Start date
2023-10-23
Primary completion
2024-10-09
Completion
2024-11-09
First posted
2024-03-29
Last updated
2025-02-04

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT06336772. Inclusion in this directory is not an endorsement.

Restylane Shaype Versus Juvederm Volux for Chin Augmentation (NCT06336772) · Clinical Trials Directory